CT-2103 in Combination With Gemcitabine in Metastatic Breast Cancer

NCT00270907 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer
Breast Cancer

Interventions

DRUG: CT-2103
DRUG: Gemcitabine

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]